Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients.

Kazandjian D, Hill E, Hultcrantz M, Rustad EH, Yellapantula V, Akhlaghi T, Korde N, Mailankody S, Dew A, Papaemmanuil E, Maric I, Kwok M, Landgren O.

Blood Cancer J. 2019 Feb 4;9(2):15. doi: 10.1038/s41408-019-0177-9.

2.

Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates.

Dulau-Florea A, Maric I, Calvo KR, Braylan RC.

Semin Hematol. 2019 Jan;56(1):65-68. doi: 10.1053/j.seminhematol.2018.05.011. Epub 2018 May 27. Review.

PMID:
30573047
3.

The challenging task of enumerating blasts in the bone marrow.

Hodes A, Calvo KR, Dulau A, Maric I, Sun J, Braylan R.

Semin Hematol. 2019 Jan;56(1):58-64. doi: 10.1053/j.seminhematol.2018.07.001. Epub 2018 Aug 16.

PMID:
30573046
4.

Advances in diagnosis of mastocytosis and hypereosinophilic syndrome.

Maric I, Sun X.

Semin Hematol. 2019 Jan;56(1):22-29. doi: 10.1053/j.seminhematol.2018.05.005. Epub 2018 May 28. Review.

PMID:
30573041
5.

Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy.

Ghaemi MS, DiGiulio DB, Contrepois K, Callahan B, Ngo TTM, Lee-McMullen B, Lehallier B, Robaczewska A, Mcilwain D, Rosenberg-Hasson Y, Wong RJ, Quaintance C, Culos A, Stanley N, Tanada A, Tsai A, Gaudilliere D, Ganio E, Han X, Ando K, McNeil L, Tingle M, Wise P, Maric I, Sirota M, Wyss-Coray T, Winn VD, Druzin ML, Gibbs R, Darmstadt GL, Lewis DB, Partovi Nia V, Agard B, Tibshirani R, Nolan G, Snyder MP, Relman DA, Quake SR, Shaw GM, Stevenson DK, Angst MS, Gaudilliere B, Aghaeepour N.

Bioinformatics. 2019 Jan 1;35(1):95-103. doi: 10.1093/bioinformatics/bty537.

6.

Cyclodextrin polymers decorated with RGD peptide as delivery systems for targeted anti-cancer chemotherapy.

Viale M, Tosto R, Giglio V, Pappalardo G, Oliveri V, Maric I, Mariggiò MA, Vecchio G.

Invest New Drugs. 2018 Dec 17. doi: 10.1007/s10637-018-0711-9. [Epub ahead of print]

PMID:
30556100
7.

Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.

Legrand F, Cao Y, Wechsler JB, Zhu X, Zimmermann N, Rampertaap S, Monsale J, Romito K, Youngblood BA, Brock EC, Makiya MA, Tomasevic N, Bebbington C, Maric I, Metcalfe DD, Bochner BS, Klion AD.

J Allergy Clin Immunol. 2018 Dec 10. pii: S0091-6749(18)31741-X. doi: 10.1016/j.jaci.2018.10.066. [Epub ahead of print]

PMID:
30543818
8.

Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease.

Carter MC, Bai Y, Ruiz-Esteves KN, Scott LM, Cantave D, Bolan H, Eisch R, Sun X, Hahn J, Maric I, Metcalfe DD.

Br J Haematol. 2018 Dec;183(5):775-782. doi: 10.1111/bjh.15624.

PMID:
30488427
9.

Female Cosmetic Genital Surgery: Patient Characteristics, Motivation, and Satisfaction.

Kalaaji A, Dryer S, Maric I, Schnegg J, Jönsson V.

Aesthet Surg J. 2018 Nov 13. doi: 10.1093/asj/sjy309. [Epub ahead of print]

PMID:
30423019
10.

Maternal Height and Risk of Preeclampsia among Race/Ethnic Groups.

Marić I, Mayo JA, Druzin ML, Wong RJ, Winn VD, Stevenson DK, Shaw GM.

Am J Perinatol. 2018 Nov 5. doi: 10.1055/s-0038-1675205. [Epub ahead of print]

PMID:
30396225
11.

Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.

Aue G, Sun C, Liu D, Park JH, Pittaluga S, Tian X, Lee E, Soto S, Valdez J, Maric I, Stetler-Stevenson M, Yuan C, Nakamura Y, Muranski P, Wiestner A.

J Immunol. 2018 Oct 1;201(7):1967-1974. doi: 10.4049/jimmunol.1800570. Epub 2018 Aug 13.

PMID:
30104242
12.

Anthropometric and glucometabolic changes in an aged mouse model of lipocalin-2 overexpression.

Principi E, Buschiazzo A, Papait A, Castagnola P, Costa D, Pece R, Maric I, Scussolini M, Marini C, Sambuceti G, Strollo F, Tavella S.

Int J Obes (Lond). 2019 Jan;43(1):189-201. doi: 10.1038/s41366-018-0171-5. Epub 2018 Aug 6.

PMID:
30082752
13.

Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma.

Salem DA, Maric I, Yuan CM, Liewehr DJ, Venzon DJ, Kochenderfer J, Stetler-Stevenson M.

Leuk Res. 2018 Aug;71:106-111. doi: 10.1016/j.leukres.2018.07.015. Epub 2018 Jul 18.

PMID:
30053652
14.

Bone Marrow as a Source of Cells for Paroxysmal Nocturnal Hemoglobinuria Detection.

Dulau-Florea AE, Young NS, Maric I, Calvo KR, Dunbar CE, Townsley DM, Winkler T, Monreal M, Jiang C, Jordan EK, Braylan RC.

Am J Clin Pathol. 2018 Jul 5. doi: 10.1093/ajcp/aqy053. [Epub ahead of print]

PMID:
29982419
15.

Richter transformation to Hodgkin lymphoma on Bruton's tyrosine kinase inhibitor therapy.

Taneja A, Jones J, Pittaluga S, Maric I, Farooqui M, Ahn IE, Wiestner A, Sun C.

Leuk Lymphoma. 2018 Jul 6:1-4. doi: 10.1080/10428194.2018.1480775. [Epub ahead of print] No abstract available.

PMID:
29978754
16.

Characterization of drug release from fibrin gels loaded with different pharmaceutical and experimental doxorubicin formulations.

Viale M, Monticone M, Maric I, Giglio V, Profumo A, Aprile A, Cilli M, Abelmoschi ML, Rocco M.

Pharmacol Rep. 2018 Aug;70(4):760-765. doi: 10.1016/j.pharep.2018.02.014. Epub 2018 Feb 21.

PMID:
29936363
17.

Gluteal Augmentation With Fat: Retrospective Safety Study and Literature Review.

Kalaaji A, Dreyer S, Vadseth L, Maric I, Jönsson V, Haukebøe TH.

Aesthet Surg J. 2019 Feb 15;39(3):292-305. doi: 10.1093/asj/sjy153.

PMID:
29931270
18.

T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.

Brudno JN, Maric I, Hartman SD, Rose JJ, Wang M, Lam N, Stetler-Stevenson M, Salem D, Yuan C, Pavletic S, Kanakry JA, Ali SA, Mikkilineni L, Feldman SA, Stroncek DF, Hansen BG, Lawrence J, Patel R, Hakim F, Gress RE, Kochenderfer JN.

J Clin Oncol. 2018 Aug 1;36(22):2267-2280. doi: 10.1200/JCO.2018.77.8084. Epub 2018 May 29.

PMID:
29812997
19.

How common is Balkan endemic nephropathy among immigrants in endemic regions?

Đukanović L, Račić M, Marić I, Maksimović Z, Simić J, Aleksić J, Stanković S, Pejović V, Ležaić V.

Int Urol Nephrol. 2018 Jul;50(7):1301-1309. doi: 10.1007/s11255-018-1889-7. Epub 2018 May 19.

PMID:
29779117
20.

Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes.

Panch SR, Bozik ME, Brown T, Makiya M, Prussin C, Archibald DG, Hebrank GT, Sullivan M, Sun X, Wetzler L, Ware J, Fay MP, Dunbar CE, Dworetzky SI, Khoury P, Maric I, Klion AD.

Blood. 2018 Aug 2;132(5):501-509. doi: 10.1182/blood-2018-02-835330. Epub 2018 May 8. Erratum in: Blood. 2018 Sep 27;132(13):1461.

PMID:
29739754
21.

Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.

Patrone S, Maric I, Rutigliani M, Lanza F, Puntoni M, Banelli B, Rancati S, Angelini G, Amaro A, Ligorio P, Defferrari C, Castagnetta M, Bandelloni R, Mosci C, DeCensi A, Romani M, Pfeffer U, Viaggi S, Coviello DA.

Genes Chromosomes Cancer. 2018 Aug;57(8):387-400. doi: 10.1002/gcc.22541.

PMID:
29689622
22.

Residential agricultural pesticide exposures and risks of preeclampsia.

Shaw GM, Yang W, Roberts EM, Aghaeepour N, Mayo JA, Weber KA, Maric I, Carmichael SL, Winn VD, Stevenson DK, English PB.

Environ Res. 2018 Jul;164:546-555. doi: 10.1016/j.envres.2018.03.020. Epub 2018 Mar 31.

PMID:
29614386
23.

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study.

Ahn IE, Farooqui MZH, Tian X, Valdez J, Sun C, Soto S, Lotter J, Housel S, Stetler-Stevenson M, Yuan CM, Maric I, Calvo KR, Nierman P, Hughes TE, Saba NS, Marti GE, Pittaluga S, Herman SEM, Niemann CU, Pedersen LB, Geisler CH, Childs R, Aue G, Wiestner A.

Blood. 2018 May 24;131(21):2357-2366. doi: 10.1182/blood-2017-12-820910. Epub 2018 Feb 26.

PMID:
29483101
24.

Quality of Life After Breast Enlargement With Implants Versus Augmentation Mastopexy: A Comparative Study.

Kalaaji A, Dreyer S, Brinkmann J, Maric I, Nordahl C, Olafsen K.

Aesthet Surg J. 2018 Nov 12;38(12):1304-1315. doi: 10.1093/asj/sjy047.

PMID:
29481590
25.

Cyclodextrin polymers as nanocarriers for sorafenib.

Giglio V, Viale M, Bertone V, Maric I, Vaccarone R, Vecchio G.

Invest New Drugs. 2018 Jun;36(3):370-379. doi: 10.1007/s10637-017-0538-9. Epub 2017 Nov 8.

PMID:
29116478
26.

Chromogranin A is not a biomarker of mastocytosis.

Hanjra P, Lee CR, Maric I, Carter M, Olivera A, Metcalfe DD, Komarow HD.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):687-689.e4. doi: 10.1016/j.jaip.2017.08.022. Epub 2017 Oct 13. No abstract available.

PMID:
29033257
27.

Linear polymers of β and γ cyclodextrins with a polyglutamic acid backbone as carriers for doxorubicin.

Oliveri V, Bellia F, Viale M, Maric I, Vecchio G.

Carbohydr Polym. 2017 Dec 1;177:355-360. doi: 10.1016/j.carbpol.2017.08.103. Epub 2017 Sep 4.

PMID:
28962779
28.

Amino- and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents.

Oliveri V, Lanza V, Milardi D, Viale M, Maric I, Sgarlata C, Vecchio G.

Metallomics. 2017 Oct 18;9(10):1439-1446. doi: 10.1039/c7mt00156h.

PMID:
28932850
29.

Effector-Triggered Self-Replication in Coupled Subsystems.

Komáromy D, Tezcan M, Schaeffer G, Marić I, Otto S.

Angew Chem Int Ed Engl. 2017 Nov 13;56(46):14658-14662. doi: 10.1002/anie.201707191. Epub 2017 Oct 9.

PMID:
28892230
30.

Host-related immunodeficiency in the development of multiple myeloma.

Dosani T, Mailankody S, Korde N, Manasanch E, Bhutani M, Tageja N, Roschewski M, Kwok M, Kazandjian D, Costello R, Burton D, Zhang Y, Liewehr D, Steinberg SM, Maric I, Landgren O.

Leuk Lymphoma. 2018 May;59(5):1127-1132. doi: 10.1080/10428194.2017.1361026. Epub 2017 Aug 9.

PMID:
28792255
31.

A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis.

Carter MC, Desai A, Komarow HD, Bai Y, Clayton ST, Clark AS, Ruiz-Esteves KN, Long LM, Cantave D, Wilson TM, Scott LM, Simakova O, Jung MY, Hahn J, Maric I, Metcalfe DD.

J Allergy Clin Immunol. 2018 Jan;141(1):180-188.e3. doi: 10.1016/j.jaci.2017.05.036. Epub 2017 Jun 16.

32.

Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma.

Salem DA, Korde N, Venzon DJ, Liewehr DJ, Maric I, Calvo KR, Braylan R, Tembhare PR, Yuan CM, Landgren CO, Stetler-Stevenson M.

Leuk Lymphoma. 2018 Jan;59(1):178-186. doi: 10.1080/10428194.2017.1321746. Epub 2017 May 25.

33.

Acaricidal and sublethal effects of a Chenopodium-based biopesticide on the two-spotted spider mite (Acari: Tetranychidae).

Musa A, Međo I, Marić I, Marčić D.

Exp Appl Acarol. 2017 Mar;71(3):211-226. doi: 10.1007/s10493-017-0118-x. Epub 2017 Apr 12.

PMID:
28405838
34.

New doxorubicin nanocarriers based on cyclodextrins.

Viale M, Giglio V, Monticone M, Maric I, Lentini G, Rocco M, Vecchio G.

Invest New Drugs. 2017 Oct;35(5):539-544. doi: 10.1007/s10637-017-0461-0. Epub 2017 Apr 4.

PMID:
28378257
35.

Dysregulation of interleukin 5 expression in familial eosinophilia.

Prakash Babu S, Chen YK, Bonne-Annee S, Yang J, Maric I, Myers TG, Nutman TB, Klion AD.

Allergy. 2017 Sep;72(9):1338-1345. doi: 10.1111/all.13146. Epub 2017 Apr 18.

36.

Antioxidant Pre-Treatment Reduces the Toxic Effects of Oxalate on Renal Epithelial Cells in a Cell Culture Model of Urolithiasis.

Kizivat T, Smolić M, Marić I, Tolušić Levak M, Smolić R, Bilić Čurčić I, Kuna L, Mihaljević I, Včev A, Tucak-Zorić S.

Int J Environ Res Public Health. 2017 Jan 23;14(1). pii: E109. doi: 10.3390/ijerph14010109.

37.

Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.

Ahn IE, Underbayev C, Albitar A, Herman SE, Tian X, Maric I, Arthur DC, Wake L, Pittaluga S, Yuan CM, Stetler-Stevenson M, Soto S, Valdez J, Nierman P, Lotter J, Xi L, Raffeld M, Farooqui M, Albitar M, Wiestner A.

Blood. 2017 Mar 16;129(11):1469-1479. doi: 10.1182/blood-2016-06-719294. Epub 2017 Jan 3.

38.

Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation.

Xie Y, Pittaluga S, Price S, Raffeld M, Hahn J, Jaffe ES, Rao VK, Maric I.

Haematologica. 2017 Feb;102(2):364-372. doi: 10.3324/haematol.2015.138081. Epub 2016 Oct 20.

39.

Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone.

Manasanch EE, de Larrea CF, Zingone A, Steinberg SM, Kwok M, Tageja N, Bhutani M, Kazandjian D, Roschewski M, Wu P, Carter G, Zuchlinski D, Mulquin M, Lamping L, Costello R, Burton D, Gil LA, Figg WD, Maric I, Calvo KR, Yuan C, Stetler-Stevenson M, Korde N, Landgren O.

Leuk Lymphoma. 2017 Mar;58(3):639-645. doi: 10.1080/10428194.2016.1214953. Epub 2016 Aug 9.

40.

Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma.

Amaro A, Parodi F, Diedrich K, Angelini G, Götz C, Viaggi S, Maric I, Coviello D, Pistillo MP, Morabito A, Mandalà M, Ghiorzo P, Visconti P, Gualco M, Anselmi L, Puzone R, Lanza F, Mosci C, Raggi F, Bosco MC, Varesio L, Zeschnigk M, Spano L, Queirolo P, Pfeffer U.

JAMA Ophthalmol. 2016 Oct 1;134(10):1125-1133. doi: 10.1001/jamaophthalmol.2016.2691.

PMID:
27532663
41.

Preparation and Antiproliferative Activity of Liposomes Containing a Combination of Cisplatin and Procainamide Hydrochloride.

Viale M, Fontana A, Maric I, Monticone M, Angelini G, Gasbarri C.

Chem Res Toxicol. 2016 Sep 19;29(9):1393-5. doi: 10.1021/acs.chemrestox.6b00207. Epub 2016 Aug 12.

PMID:
27501273
42.

T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.

Ali SA, Shi V, Maric I, Wang M, Stroncek DF, Rose JJ, Brudno JN, Stetler-Stevenson M, Feldman SA, Hansen BG, Fellowes VS, Hakim FT, Gress RE, Kochenderfer JN.

Blood. 2016 Sep 29;128(13):1688-700. doi: 10.1182/blood-2016-04-711903. Epub 2016 Jul 13.

43.

Monoclonal gammopathy-associated pure red cell aplasia.

Korde N, Zhang Y, Loeliger K, Poon A, Simakova O, Zingone A, Costello R, Childs R, Noel P, Silver S, Kwok M, Mo C, Young N, Landgren O, Sloand E, Maric I.

Br J Haematol. 2016 Jun;173(6):876-83. doi: 10.1111/bjh.14012. Epub 2016 Mar 21.

44.

SENP1, but not fetal hemoglobin, differentiates Andean highlanders with chronic mountain sickness from healthy individuals among Andean highlanders.

Hsieh MM, Callacondo D, Rojas-Camayo J, Quesada-Olarte J, Wang X, Uchida N, Maric I, Remaley AT, Leon-Velarde F, Villafuerte FC, Tisdale JF.

Exp Hematol. 2016 Jun;44(6):483-490.e2. doi: 10.1016/j.exphem.2016.02.010. Epub 2016 Mar 4.

PMID:
26952840
45.

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.

Brudno JN, Somerville RP, Shi V, Rose JJ, Halverson DC, Fowler DH, Gea-Banacloche JC, Pavletic SZ, Hickstein DD, Lu TL, Feldman SA, Iwamoto AT, Kurlander R, Maric I, Goy A, Hansen BG, Wilder JS, Blacklock-Schuver B, Hakim FT, Rosenberg SA, Gress RE, Kochenderfer JN.

J Clin Oncol. 2016 Apr 1;34(10):1112-21. doi: 10.1200/JCO.2015.64.5929. Epub 2016 Jan 25.

46.

Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome.

Khoury P, Desmond R, Pabon A, Holland-Thomas N, Ware JM, Arthur DC, Kurlander R, Fay MP, Maric I, Klion AD.

Allergy. 2016 Jun;71(6):803-10. doi: 10.1111/all.12843. Epub 2016 Mar 2.

47.

Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study.

Dumitriu B, Ito S, Feng X, Stephens N, Yunce M, Kajigaya S, Melenhorst JJ, Rios O, Scheinberg P, Chinian F, Keyvanfar K, Battiwalla M, Wu CO, Maric I, Xi L, Raffeld M, Muranski P, Townsley DM, Young NS, Barrett AJ, Scheinberg P.

Lancet Haematol. 2016 Jan;3(1):e22-9. doi: 10.1016/S2352-3026(15)00227-6. Epub 2015 Dec 17.

48.

CD30-targeting drugs: cure for mastocytosis?

Maric I.

Blood. 2015 Dec 24;126(26):2771-3. doi: 10.1182/blood-2015-11-678631. No abstract available.

49.

Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging.

Bhutani M, Turkbey B, Tan E, Korde N, Kwok M, Manasanch EE, Tageja N, Mailankody S, Roschewski M, Mulquin M, Carpenter A, Lamping E, Minter AR, Weiss BM, Mena E, Lindenberg L, Calvo KR, Maric I, Usmani SZ, Choyke PL, Kurdziel K, Landgren O.

Leuk Lymphoma. 2016 May;57(5):1114-21. doi: 10.3109/10428194.2015.1090572. Epub 2016 Apr 7.

50.

Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia.

Sheikh V, Porter BO, DerSimonian R, Kovacs SB, Thompson WL, Perez-Diez A, Freeman AF, Roby G, Mican J, Pau A, Rupert A, Adelsberger J, Higgins J, Bourgeois JS Jr, Jensen SM, Morcock DR, Burbelo PD, Osnos L, Maric I, Natarajan V, Croughs T, Yao MD, Estes JD, Sereti I.

Blood. 2016 Feb 25;127(8):977-88. doi: 10.1182/blood-2015-05-645077. Epub 2015 Dec 16.

Supplemental Content

Support Center